Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Planning Committee: • Annette Hood discloses that she is a member of the Amgen speakers’ bureau. • Denise Murcek discloses other financial/material support as an employee of the VA Medical Center. • Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care. • Kyra Trappett discloses other financial/material support as an employee of DaVita.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Review the prevalence of hypertension in hemodialysis and the associated risks of uncontrolled hypertension. • Discuss the underlying causes of hypertension in hemodialysis. • Identify blood pressure goals for hemodialysis patients. • Review the blood pressure medication classes used to treat hypertension in hemodialysis. • Discuss major side effects and interactions associated with each drug class.